Conference abstract · 5 Dec 2016
Conference abstractPublished 5 Dec 2016
A pharmacological study of a new spiro-cyclic benzopyran activator of the cardiac mitoKATP channel on ischemia/reperfusion-induced ventricular arrhythmias
Bulent Ecevit University, Turkey; University of Pisa, Italy; Harran University, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background/Introduction: 4âÂ?Â?-(N-(4-acetamidobenzyl))-2,2-dimethyl-2,3-dihydro-5âÂ?Â?H-spiro [chromene-4,2âÂ?Â?-[1,4]oxazinan]- 5âÂ?Â?-one (compound A) was synthesized as a new spiro-cyclic benzopyran activator of the cardiac mitochondrial ATP-dependent potassium (mitoKATP) channels. A previous study showed the anti-ischemic properties of Compound A. Purpose: This study was performed to research the effect compound A on ischemia/reperfusion (I/R)-induced ventricular arrhythmias. In our previous study, we suggest that both mitoKATP channel activation and sarcolemmal ATP-dependent potassium (sarcKATP) channel inhibition confer protection against I/R-induced arrhythmias; therefore, we also aimed to test the hypothesis that a combination of mitoKATP channel activation and sarcKATP channel inhibition may be even more effective at decreasing ventricular arrhythmias. Methods: We performed myocardial I/R by ligating the left main coronary artery for 6 minutes followed by loosening the bond at the coronary artery for 6 minutes in anesthetized rats. The experimental groups were as follows: (1) Vehicle control, (2) Compound A (3 mg/kg) (3) Compound A (10 mg/kg.) (4) Diazoxide (5) HMR 1098 (6) Compound A (10 mg/kg)+HMR 1098 and (7) Diazoxide+HMR 1098 group. Results: Compoud A at a dose of 10 mg/kg decreased both the arrhythmia score and the total length of arrhythmias (P<0.01). Diazoxide at a dose of 40 mg/kg, a selective mitoKATP channel opener as a reference drug only decreased the total length of arrhythmias (P<0.01). Compound A at a dose of 10 mg/kg was more effective at decreasing the duration of arrhythmias than a dose of 3 mg/kg of compound A and diazoxide. The combination of both diazoxide and compound A with HMR 1098, a selective sarcKATP channel blocker, did not exhibit any additive or synergic effect on the antiarrhythmic effect of each drug alone. Conclusion(s): These results reveal that compound A may have a dose-dependent antiarrythmic effect, which is more pronounced than the antiarrhythmic effect of diazoxide. Both mitoKATP channel activation and sarcKATP channel inhibition at the same time may not reveal any additive antiarrhythmic effect on I/R-induced arrhythmias.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 2 Aug 2023
Pharmacological Modulation of HCN Channels: A Novel Approach to Cardiac Arrhythmia Control
Conference abstract · 4 Aug 2014
Protective effect of diltiazem and fenofibrate against ischemia-reperfusion induced cardiac arrhythmias in isolated rat hearts
Conference abstract · 14 Apr 2014
Disrupting KATP channels diminishes the estrogen-mediated protection in female mutant mice during ischemia-reperfusion
Short communication · 29 Feb 2020
Ginsenoside Rg2 Attenuates Ischemia/Reperfusion-induced Injury to Spinal Cord in Rats
More from this journal
The newest in Clinical and Experimental Cardiology.
Short communication · 4 Aug 2026
An effective determination method for aortic valve replacement through minimally invasive lower median sternotomy
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Ersoz Gonca”
- BylineArticles whose byline prints “Simona Rapposelli”
- BylineArticles whose byline prints “Faruk Darici”
- BylineArticles whose byline prints “Maria Digiacomo”
- BylineArticles whose byline prints “Zehra Yilmaz”

